Inventor · disambiguated record
Mark I. Greene
Also filed as: GREENE MARK · GREENE MARK I
73 granted patents·21 pending applications·1,797 citations·filing 1982–2025
99Inventor score
Top patents by PatentIndex Score
94 records- 0196US6740665B1Tyrosine kinase inhibitors and methods of using the sameFiled 2000·Granted May 25, 2004·76 cites·6 claims
- 0296US5705157AMethods of treating cancerous cells with anti-receptor antibodiesUNIV PENNSYLVANIA·Filed 1994·Granted Jan 6, 1998·190 cites·6 claims
- 0395US6673771B1Methods of inhibiting osteoclast activityUNIV PENNSYLVANIA·Filed 2000·Granted Jan 6, 2004·43 cites·7 claims
- 0494US8765810B2Tumor necrosis factor inhibitorsUNIV PENNSYLVANIA·Filed 2012·Granted Jul 1, 2014·46 cites·12 claims
- 0594US6417168B1Compositions and methods of treating tumorsUNIV PENNSYLVANIA·Filed 1998·Granted Jul 9, 2002·120 cites·29 claims
- 0694US5824311ATreatment of tumors with monoclonal antibodies against oncogene antigensUNIV PENNSYLVANIA·Filed 1994·Granted Oct 20, 1998·382 cites·24 claims
- 0794US5637677ABiologically active compounds and methods of constructing and using the sameUNIV PENNSYLVANIA·Filed 1992·Granted Jun 10, 1997·138 cites·35 claims
- 0893US10371705B2Atomic description of immune complex that causes heparin-induced thrombocytopeniaUNIV PENNSYLVANIA·Filed 2015·Granted Aug 6, 2019·4 cites·5 claims
- 0993US7662374B2Monoclonal antibodies to activated erbB family members and methods of use thereofUNIV PENNSYLVANIA·Filed 2002·Granted Feb 16, 2010·36 cites·39 claims
- 1093US5663144ACompounds that bind to p185 and methods of using the sameUNIV PENNSYLVANIA·Filed 1995·Granted Sep 2, 1997·105 cites·10 claims
- 1192US8728479B2Antigen-binding proteins comprising recombinant protein scaffoldsGREENE MARK I·Filed 2010·Granted May 20, 2014·21 cites·6 claims
- 1292US7625558B2Compositions and methods of treating tumorsUNIV PENNSYLVANIA·Filed 2002·Granted Dec 1, 2009·43 cites·41 claims
- 1390US12282028B2Atomic description of immune complex that causes heparin-induced thrombocytopeniaUNIV PENNSYLVANIA·Filed 2024·Granted Apr 22, 2025·0 cites·5 claims
- 1488US7781566B2ErbB interface peptidomimetics and methods of use thereofUNIV PENNSYLVANIA·Filed 2009·Granted Aug 24, 2010·4 cites·5 claims
- 1587US11524999B2Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopeniaUNIV PENNSYLVANIA·Filed 2018·Granted Dec 13, 2022·2 cites·18 claims
- 1687US6743592B1Methods, systems and kits for immuno-detection of epitopes expressed on moleculesUNIV PENNSYLVANIA·Filed 2000·Granted Jun 1, 2004·28 cites·14 claims
- 1786US11435362B2Atomic description of immune complex that causes heparin-induced thrombocytopeniaUNIV PENNSYLVANIA·Filed 2019·Granted Sep 6, 2022·1 cites·8 claims
- 1886US8680047B2Fas peptide mimetics and uses thereofGREENE MARK I·Filed 2011·Granted Mar 25, 2014·7 cites·22 claims
- 1986US7906624B2Binding peptidomimetics and uses of the sameUNIV PENNSYLVANIA·Filed 2005·Granted Mar 15, 2011·9 cites·1 claims
- 2086US5464751ALigand for the neu gene productUNIV PENNSYLVANIA·Filed 1991·Granted Nov 7, 1995·74 cites·14 claims
- 2184US11913963B2Atomic description of immune complex that causes heparin-induced thrombocytopeniaUNIV PENNSYLVANIA·Filed 2022·Granted Feb 27, 2024·0 cites·14 claims
- 2284US8057799B2ErbB interface peptidomimetics and methods of use thereofGREENE MARK I·Filed 2009·Granted Nov 15, 2011·2 cites·4 claims
- 2384US7179785B2Compounds that bind to p185 and methods of using the sameUNIV PENNSYLVANIA·Filed 2002·Granted Feb 20, 2007·7 cites·22 claims
- 2482US7638598B2ErbB interface peptidomimetics and methods of use thereofUNIV PENNSYLVANIA·Filed 2002·Granted Dec 29, 2009·10 cites·16 claims
- 2582US7361464B2Method, systems and kits for immuno-detection of epitopes expressed on moleculesUNIV PENNSYLVANIA·Filed 2004·Granted Apr 22, 2008·13 cites·24 claims
- 2682US5574009AMethod of stimulating myelination of cellsUNIV PENNSYLVANIA·Filed 1994·Granted Nov 12, 1996·43 cites·5 claims
- 2780US7745577B2Compounds that bind to P185 and methods of using the sameUNIV PENNSYLVANIA·Filed 2005·Granted Jun 29, 2010·2 cites·5 claims
- 2880US6265535B1Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their usesUNIV PENNSYLVANIA·Filed 1997·Granted Jul 24, 2001·54 cites·21 claims
- 2980US5837523ACompositions and methods of treating tumorsUNIV PENNSYLVANIA·Filed 1995·Granted Nov 17, 1998·68 cites·29 claims
- 3080US2025251405A1Atomic Description of Immune Complex that Causes Heparin-Induced ThrombocytopeniaUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 3179US8019557B2Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the sameUNIV PENNSYLVANIA·Filed 2009·Granted Sep 13, 2011·2 cites·5 claims
- 3278US12304948B2Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopeniaUNIV PENNSYLVANIA·Filed 2022·Granted May 20, 2025·0 cites·18 claims
- 3378US8445644B2ErbB interface peptidomimetics and methods of use thereofGREENE MARK I·Filed 2010·Granted May 21, 2013·1 cites·22 claims
- 3478US6682739B1Methods of inhibiting osteoclastogenesisUNIV PENNSYLVANIA·Filed 2000·Granted Jan 27, 2004·8 cites·41 claims
- 3578US6100377AConstrained peptidesUNIV PENNSYLVANIA·Filed 1994·Granted Aug 8, 2000·34 cites·16 claims
- 3678US5334702ACompositions which are immunologically crossreactive with antibodies and preparative methods thereforUNIV ILLINOIS·Filed 1992·Granted Aug 2, 1994·40 cites·1 claims
- 3777US8962793B2ErbB interface peptidomimetics and methods of use thereofUNIV PENNSYLVANIA·Filed 2013·Granted Feb 24, 2015·2 cites·10 claims
- 3877US8003628B2Methods of inhibiting osteoclast activityUNIV PENNSYLVANIA·Filed 2009·Granted Aug 23, 2011·0 cites·7 claims
- 3977US7045286B2Methods of detecting molecules expressing selected epitopes via fluorescent dyesUNIV PENNSYLVANIA·Filed 2001·Granted May 16, 2006·15 cites·16 claims
- 4075US8022176B2FAS peptide mimetics and uses thereofUNIV PENNSYLVANIA·Filed 2007·Granted Sep 20, 2011·1 cites·14 claims
- 4175US7341831B2Method for immuno-detection of epitopesUNIV PENNSYLVANIA·Filed 2001·Granted Mar 11, 2008·13 cites·24 claims
- 4275US2010040618A1Prevention of tumors with monoclonal antibodies against neuTRUSTEE OF THE UNIVERSITY OF P·Filed 2009·Application pending·0 cites
- 4374US4490358AScreening vaccines and immunization processHARVARD COLLEGE·Filed 1982·Granted Dec 25, 1984·31 cites·8 claims
- 4474US2009104191A1Prevention of tumors with monoclonal antibodies against neuUNIV PENNSYLVANIA·Filed 2008·Application pending·0 cites
- 4573US8710068B2Method of treating cancer using a survivin inhibitorBEREZOV ALAN·Filed 2010·Granted Apr 29, 2014·3 cites·13 claims
- 4673US7566741B2Methods of inhibiting osteoclast activityUNIV PENNSYLVANIA·Filed 2003·Granted Jul 28, 2009·2 cites·4 claims
- 4772US5919764ACompounds that bind to p185 and methods of using the sameUNIV PENNSYLVANIA·Filed 1997·Granted Jul 6, 1999·34 cites·18 claims
- 4870US8497285B2Therapy of autoimmune colitis using a TIP60 inhibitorGREENE MARK I·Filed 2011·Granted Jul 30, 2013·1 cites·20 claims
- 4969US8785419B2Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the sameMURALI RAMACHANDRAN·Filed 2011·Granted Jul 22, 2014·1 cites·5 claims
- 5069US6733752B1Prevention of tumors with monoclonal antibodies against neuUNIV PENNSYLVANIA·Filed 1994·Granted May 11, 2004·18 cites·17 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark I. Greene files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →